+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Celiac Disease Drugs Market Research Report by Drug (First Line of Treatment and Second Line of Treatment), Type, End-User, Indication, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 255 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5674198
UP TO OFF until Mar 31st 2023
The Global Celiac Disease Drugs Market size was estimated at USD 1,291.23 million in 2022, USD 1,421.25 million in 2023, and is projected to grow at a CAGR of 10.52% to reach USD 2,875.59 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Celiac Disease Drugs Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Celiac Disease Drugs Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Celiac Disease Drugs Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Celiac Disease Drugs Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Celiac Disease Drugs Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug, the market is studied across First Line of Treatment and Second Line of Treatment.
  • Based on Type, the market is studied across Steroids & Immunosuppressive Drugs, Therapeutic Vaccines, and Vitamins & Dietary Supplements.
  • Based on End-User, the market is studied across Clinical Research Organizations, Hospitals & Clinics, and Research & Academic Institutes.
  • Based on Indication, the market is studied across Anorexia, Bloating, Diarrhea, Distension, Fatigue, and Gas.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Celiac Disease Drugs Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Celiac Disease Drugs Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Celiac Disease Drugs Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Celiac Disease Drugs Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Celiac Disease Drugs Market, including 9 Meters Biopharma Inc., Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Artielle Immunotherapeutics Inc., BioLineRx Ltd., Bristol Myers Squibb Company, Calypso Biotech, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd, Johnson & Johnson Services, Inc, Precigen Inc., Sanofi S.A., Takeda Pharmaceutical Co. Ltd., Vactech Oy, and Zedira GmbH.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Celiac Disease Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Celiac Disease Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Celiac Disease Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Celiac Disease Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Celiac Disease Drugs Market?
6. What is the market share of the leading vendors in the Global Celiac Disease Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Celiac Disease Drugs Market?
Frequently Asked Questions about the Global Celiac Disease Drugs Market

What is the estimated value of the Global Celiac Disease Drugs Market?

The Global Celiac Disease Drugs Market was estimated to be valued at $1291.23 Million in 2022.

What is the growth rate of the Global Celiac Disease Drugs Market?

The growth rate of the Global Celiac Disease Drugs Market is 10.5%, with an estimated value of $2875.59 Million by 2030.

What is the forecasted size of the Global Celiac Disease Drugs Market?

The Global Celiac Disease Drugs Market is estimated to be worth $2875.59 Million by 2030.

Who are the key companies in the Global Celiac Disease Drugs Market?

Key companies in the Global Celiac Disease Drugs Market include 9 Meters Biopharma Inc., Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Artielle Immunotherapeutics Inc., BioLineRx Ltd., Bristol Myers Squibb Company and GlaxoSmithKline PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in prevalence of celiac disease
5.1.1.2. Rising dependence of gluten containing and ready-to-eat packaged food
5.1.1.3. Increase government and private organizations support towards celiac disease awareness
5.1.2. Restraints
5.1.2.1. Restricted availability of treatment options
5.1.3. Opportunities
5.1.3.1. Rising R&D activities to introduce advanced celiac disease drugs
5.1.3.2. Technological advancements and increasing modernization in the healthcare sector
5.1.4. Challenges
5.1.4.1. Strict government regulations for drug approval
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Celiac Disease Drugs Market, by Drug
6.1. Introduction
6.2. First Line of Treatment
6.3. Second Line of Treatment

7. Celiac Disease Drugs Market, by Type
7.1. Introduction
7.2. Steroids & Immunosuppressive Drugs
7.3. Therapeutic Vaccines
7.4. Vitamins & Dietary Supplements

8. Celiac Disease Drugs Market, by End-User
8.1. Introduction
8.2. Clinical Research Organizations
8.3. Hospitals & Clinics
8.4. Research & Academic Institutes

9. Celiac Disease Drugs Market, by Indication
9.1. Introduction
9.2. Anorexia
9.3. Bloating
9.4. Diarrhea
9.5. Distension
9.6. Fatigue
9.7. Gas

10. Americas Celiac Disease Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Celiac Disease Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Celiac Disease Drugs Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Product Portfolio Analysis, By Key Player
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. 9 Meters Biopharma Inc.
14.2. Adaptive Biotechnologies Corp.
14.3. Almirall SA
14.4. Amgen Inc.
14.5. AMYRA Biotech AG
14.6. Artielle Immunotherapeutics Inc.
14.7. BioLineRx Ltd.
14.8. Bristol Myers Squibb Company
14.9. Calypso Biotech
14.10. GlaxoSmithKline PLC
14.11. Glenmark Pharmaceuticals Ltd
14.12. Johnson & Johnson Services, Inc
14.13. Precigen Inc.
14.14. Sanofi S.A.
14.15. Takeda Pharmaceutical Co. Ltd.
14.16. Vactech Oy
14.17. Zedira GmbH

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL CELIAC DISEASE DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL CELIAC DISEASE DRUGS MARKET DYNAMICS
FIGURE 11. GLOBAL CELIAC DISEASE DRUGS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2022 VS 2030 (%)
FIGURE 13. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG, 2030
FIGURE 15. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY FIRST LINE OF TREATMENT, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY SECOND LINE OF TREATMENT, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 18. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 20. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY STEROIDS & IMMUNOSUPPRESSIVE DRUGS, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY THERAPEUTIC VACCINES, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 24. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 26. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 30. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 31. GLOBAL CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2030
FIGURE 32. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY ANOREXIA, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY BLOATING, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DIARRHEA, 2018-2030 (USD MILLION)
FIGURE 35. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DISTENSION, 2018-2030 (USD MILLION)
FIGURE 36. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY FATIGUE, 2018-2030 (USD MILLION)
FIGURE 37. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY GAS, 2018-2030 (USD MILLION)
FIGURE 38. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 40. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 41. AMERICAS CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 42. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. CANADA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 48. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 49. UNITED STATES CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 50. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 52. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 53. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 54. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. CHINA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. INDIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 68. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 70. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. ITALY CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. POLAND CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. QATAR CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. GLOBAL CELIAC DISEASE DRUGS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 92. GLOBAL CELIAC DISEASE DRUGS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 93. GLOBAL CELIAC DISEASE DRUGS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL CELIAC DISEASE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY FIRST LINE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY FIRST LINE OF TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY FIRST LINE OF TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY SECOND LINE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY SECOND LINE OF TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY SECOND LINE OF TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY STEROIDS & IMMUNOSUPPRESSIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY STEROIDS & IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY STEROIDS & IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY THERAPEUTIC VACCINES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY ANOREXIA, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY ANOREXIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY ANOREXIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY BLOATING, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY BLOATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY BLOATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DIARRHEA, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DISTENSION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DISTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY DISTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY FATIGUE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY FATIGUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY FATIGUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY GAS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CELIAC DISEASE DRUGS MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. CANADA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 70. CANADA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CANADA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 75. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. CHINA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 96. CHINA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 97. CHINA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. CHINA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. CHINA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. INDIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 101. INDIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 102. INDIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. INDIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. INDIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 111. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 112. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 141. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 142. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 158. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 163. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 168. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 173. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. ITALY CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 187. ITALY CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 188. ITALY CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. ITALY CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. ITALY CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 197. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 198. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 202. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 203. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. POLAND CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 207. POLAND CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 208. POLAND CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. POLAND CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. POLAND CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. QATAR CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 212. QATAR CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 213. QATAR CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. QATAR CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. QATAR CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 232. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 233. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 241. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 242. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 243. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 247. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 248. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 256. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 258. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 261. GLOBAL CELIAC DISEASE DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 262. GLOBAL CELIAC DISEASE DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 263. GLOBAL CELIAC DISEASE DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 264. GLOBAL CELIAC DISEASE DRUGS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 265. GLOBAL CELIAC DISEASE DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 266. GLOBAL CELIAC DISEASE DRUGS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 267. GLOBAL CELIAC DISEASE DRUGS MARKET MERGER & ACQUISITION
TABLE 268. GLOBAL CELIAC DISEASE DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 269. GLOBAL CELIAC DISEASE DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 270. GLOBAL CELIAC DISEASE DRUGS MARKET INVESTMENT & FUNDING
TABLE 271. GLOBAL CELIAC DISEASE DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 272. GLOBAL CELIAC DISEASE DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

  • 9 Meters Biopharma Inc.
  • Adaptive Biotechnologies Corp.
  • Almirall SA
  • Amgen Inc.
  • AMYRA Biotech AG
  • Artielle Immunotherapeutics Inc.
  • BioLineRx Ltd.
  • Bristol Myers Squibb Company
  • Calypso Biotech
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd
  • Johnson & Johnson Services, Inc
  • Precigen Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Co. Ltd.
  • Vactech Oy
  • Zedira GmbH

Methodology

Loading
LOADING...